Health IT, Policy

Meaningful Use is not dead: It’s reincarnated

Last week, CMS’s acting administrative director Andy Slavitt made an announcement that the Meaningful Use(MU) Program as we know it is effectively over. Many people rejoiced at the “death” of MU. They failed to listen to all of his words. He did not say that MU is dead. He said it is being replaced with something […]

gravestone dead grave yardLast week, CMS’s acting administrative director Andy Slavitt made an announcement that the Meaningful Use(MU) Program as we know it is effectively over.

Many people rejoiced at the “death” of MU. They failed to listen to all of his words.

He did not say that MU is dead. He said it is being replaced with something better.

Meaningful Use is not dead, it is reincarnated as we were aware it would be for many months now.

Last year, the MACRA  bill was signed into law and in the pages of minutae and legal language, it was outlined what would happen to meaningful use. Basically, the PQRS (Physician Quality Reporting System) and MU would be joined into one and give birth to MIPS (Merit-based incentive payment system). Under the new program, doctors are required to report clinical information as well as IT data. What the metrics we are now required to report is unknown as of yet.

CMS hinted that they heard our concerns over the ill-devised MU program. However, our voices are not what killed it: the technology and EHR vendors did. A key functionality of MU was supposed to be interoperability.

However, EHR vendors failed to create any significant degree of interoperabilty. The technology just has not proved capable of building effective bridges to connect systems. And the vendors are not willing to work together to make it happen. There is too much competition and they all want to sell their own products.  We will never see any true interoperability.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

The government spent millions on a program that never had the capacity to work. They forced healthcare providers to participate in a program that did not possess the ability to work the way it was supposed under the threat of financial penalties. And, when the time came  to focus on stage 3, the realization that technology doesn’t work in the way they were trying to force us to use it was realized. MU as we know it died because it was fatally flawed.

However, the government, after spending millions of dollars on it and forcing it upon us against much public outcries will never admit this. Instead, they planned out the new and improved version of their ill-devised, terminally afflicted MU program, and put it into law under the auspices of the MACRA bill.

Doctors used to have a choice whether or not to comply with this onerous, time-consuming monstrosity of a program. Sure, we would be hit with penalties against our reimbursements. Many of us thought MU was not worth the amount of money CMS would penalize us. I personally completed the first 2 stages but I understand how many would not want to.

MIPS will entail parts of both the PQRS and MU programs. And doctors no longer have any choice in it. If we want to be paid for our services, we must comply. It is now federal law.  Doctors and other providers will be paid based on their data and outcomes, not the services they provide to their patients.

Imagine this scenario: one of my patients is a diabetic. He likes to eat cookies and I have spent hours trying to encourage him to change to a more healthy diet. He listens and does what he wants. His HbA1C is 11.5.

Dr. Jones has a diabetic who is really into healthy lifestyle. His HbA1c is 6.1. Dr. Jones spends 10 minutes with him, refills his prescriptions and sends him on his way.

Who will get paid more under MIPS? The doctor who spent more time and effort with the pt or the doctor with healthier patients? It seems counter-intuitive but time and effort will not be appreciated under this system.

We will be penalized for our patients’ bad choices and disincentivized to make the effort to get them to change.

In fact, patients who are more complicated and have more chronic diseases are going to be greatly harmed under this system. They need more time and care but doctors cannot afford to do it for free. The  more ill patients will find it hard to access the medical system.

For those who say MU is dead, it is coming back with a vengeance. Doctors and patients both stand to lose greatly in such a system.  Are we going to celebrate the meaningless demise of a meaningless system and watch as it rolls out revamped and steam rolls us over? Or is it time for public outcry against big brother legally taking patients’ data out of the exam room?

Photo: Flickr user Andrew Dyson

Topics